The model incorporates clinical, serological, and gene expression factors, and could be used to tailor treatment choices.
The study will involve assaying proteomic markers for dementias including Alzheimer's disease, and understanding genomic markers as part of the normal aging process.
Transcriptional response of pro-inflammatory and antiviral genes in the face of childhood trauma is linked to PTSD but can be mitigated.
The addition of certain kinds of information could help clinical labs determine whether variants of uncertain significance are pathogenic or benign.
The test, which EGL plans to launch clinically this summer, is designed to boost diagnostic yield by helping to resolve variants of unknown significance.
Researchers discussed using WGS to predict antibacterial resistance, to inform influenza vaccine development, and to diagnose and build drug resistance profiles for tuberculosis.
The Atlanta-based firm seeks to develop antiviral genome-targeting therapies for HBV and HPV using CRISPR/Cas9.
The Belgium-based testing firm believes acquiring the university laboratory will strengthen its position in specialty clinical diagnostic testing.
Using TCGA and other data, two teams have identified subsets of glioma with distinct molecular markers, mutation patterns, and survival outcomes.
Scientists from Emory University have found that Cas9 from Francisella novicida can inhibit viral protein production.
The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.
A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.
The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.
In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.